Pfizer Recalls Another Blood Pressure Medication

April 25, 2022

The pharmaceutical firm Pfizer has voluntary recalled a blood stress remedy for the second time in a month.

Pfizer is recalling 5 plenty of blood stress medication Accupril due to elevated ranges of a nitrosamine, Nnitroso-quinapril, the corporate mentioned in a information launch posted Friday on the FDA web site.

Nitrosamines are present in water and meals, together with grilled meats and dairy merchandise, however impurities might improve an individual’s most cancers danger over lengthy durations of time, Pfizer mentioned.

Accupril is used to decrease blood stress and handle coronary heart failure. Pfizer mentioned it has not obtained any reviews of antagonistic reactions by folks taking the drug.

“Pfizer believes the profit/danger profile of the merchandise stays optimistic based mostly on at the moment out there knowledge. Though long-term ingestion of Nnitroso-quinapril could also be related to a possible elevated most cancers danger in people, there isn’t a rapid danger to sufferers taking this remedy,” the corporate mentioned.

The Accupril tables are bought in 10-, 20- and 40-mg doses. The affected lot numbers are DR9639, DX8682, DG1188, DX6031, and CK6260.

Sufferers taking the product ought to speak to their physician. Sufferers with the affected product ought to name 888-345-0481.

Pfizer recalled one other blood stress remedy on March 22.

The affected merchandise in that recall are quinapril HCl/hydrochlorothiazide (Accuretic) tablets that Pfizer distributes, and two licensed generics, quinapril plus hydrochlorothiazide and quinapril HCl/hydrochlorothiazide, distributed by Greenstone. The recall is over increased than accepted ranges of N-nitroso-quinapril, a compound referred to as a nitrosamine.